Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,4 USD | -10,11% | -40,00% | -64,37% |
Omzet 2024 * | 25,22 mln. 23,52 mln. | Omzet 2025 * | 32,65 mln. 30,45 mln. | Marktkapitalisatie | 3,55 mln. 3,31 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -24 mln. -22,38 mln. | Nettowinst (verlies) 2025 * | -9 mln. -8,39 mln. | EV/omzet 2024 * | 0,14 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,11 x |
K/w-verhouding 2024 * |
-0,15
x | K/w-verhouding 2025 * |
-0,67
x | Werknemers | 25 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,21% |
Recentste transcriptie over Eiger BioPharmaceuticals, Inc.
1 dag | -10,11% | ||
1 week | -40,00% | ||
Lopende maand | -52,05% | ||
1 maand | -52,05% | ||
3 maanden | -59,99% | ||
6 maanden | -64,44% | ||
Lopend jaar | -64,37% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Apelian
CEO | Chief Executive Officer | 59 | 14-06-17 |
Director of Finance/CFO | 58 | 13-04-23 | |
James Vollins
CMP | Compliance Officer | 55 | 13-04-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 57 | 18-07-22 | |
Thomas Dietz
CHM | Chairman | 60 | 22-03-16 |
David Apelian
CEO | Chief Executive Officer | 59 | 14-06-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 0 M€ | 0,00% | - | |
0.00% | 18 M€ | +3,15% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
29-04-24 | 2,4 | -10,11% | 5 307 |
26-04-24 | 2,67 | -12,17% | 18 908 |
25-04-24 | 3,04 | -19,95% | 17 019 |
24-04-24 | 3,798 | -3,86% | 14 300 |
23-04-24 | 3,95 | -1,25% | 28 020 |
uitgestelde koers OTC Markets, 29 april 2024 om 21:25 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-64,37% | 3,55 mln. | |
+1,77% | 42,86 mld. | |
+46,00% | 41,36 mld. | |
+12,24% | 42,74 mld. | |
-8,83% | 27,68 mld. | |
+7,44% | 25,15 mld. | |
-23,01% | 18,63 mld. | |
+30,56% | 12,37 mld. | |
-1,82% | 11,92 mld. | |
+8,35% | 11,21 mld. |